Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and children, including community‑acquired pneumonia, acute bacterial sinusitis, uncomplicated urinary tract infection, skin and soft‑tissue infections, and acute exacerbations of chronic bronchitis.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Levalox is indicated for several bacterial infections affecting the respiratory, urinary and skin systems.

- Community‑acquired pneumonia: eradicates the causative pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Uncomplicated urinary tract infection: eliminates uropathogens and relieves symptoms. - Skin and soft‑tissue infections: treats bacterial cellulitis and related conditions. - Acute exacerbations of chronic bronchitis: controls bacterial overgrowth and reduces exacerbation severity.

Levalox may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: potential cardiac arrhythmias. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levalox, clinicians should consider several safety factors.

- Renal impairment: assess kidney function and adjust dose if necessary. - History of tendon disorders: avoid use in patients with prior tendon injury or tendon‑related conditions. - Cardiac risk: evaluate QT prolongation risk, especially with concomitant drugs. - Pregnancy and lactation: use only if the potential benefit outweighs unknown risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levalox can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of central nervous system stimulation. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Drugs that prolong QT interval (e.g., macrolides, fluoroquinolones): monitor cardiac rhythm.